| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |